Current Market Information

Last Trade Price (LTP) 337.00 Updated Date 08 October, 2026 Change 0.00 % Open Price 337.00 Day's Range 337.00 - 337.00     Total Trade 0 Total Volume 0 Close Price 337.00 Previous Close Price 337.00 Market Capital in BDT (mn) 10529.102

Contact Information

Designation Name Mobile Number Email Chairman Kazi Harun or Rashid 01792705193 kaziharun99@gmail.com MD Prof. Dr. A K M Sadrul Islam 01755538544 sadrul05@gmail.com CFO Md. Jasim Uddin 01709645001 jasim.uddin@ibnsinapharma.com Company Secretary Md. Kabir Hossain 01713094075 kabirhossain@ibnsinapharma.com Office Address Tanin Center, 3 Asad Gate, Mirpur Road, Mohammadpur, Dhaka-1207 Phone : 02-41022151-58 Fax : 880 - 02 - 9118847 Email : ibnsina@bangla.net, Website : http://www.ibnsinapharma.com Factory Address Shafipur, Kaliakor, Gazipur

Basic Information

Authorized Capital in BDT* (mn) 500.00 Paid-up Capital in BDT* (mn) 312.44 Face Value 10 Paid up Share 31243627     Market Lot 1 Sector PHARMA & CHEMICALS Market Category A

Other Information

Listing Year 1996 Debut Trade Date 26 December, 1996 Type of Instrument     52 Week's Range 280.00 - 364.20 Year End 30 June Reserve / Surplus(mn) 3614.47 Remarks Note

Share Holding Percentage

Sponsor/Director Govt. Institute Foreign Public As on 31-Aug, 2026 44.68 0 25.37 0 29.95 As on 31-Jul, 2026 44.68 0 25.13 0 30.19 As on 31-May, 2026 44.68 0 25.66 0 29.66 As on 30-Jun, 2026 (year ended) 44.68 0 25.77 0 29.55     Remarks Note     Credit Rating Status Credit Rating Year Long Term Short Term Outlook Validity Date Credit Rating Company Nov 10, 2025 AA+ ST-1 Stable Nov 09, 2026 Alpha Credit Rating Limited Nov 10, 2024 AA+ ST-1 Stable Nov 09, 2025 Alpha Credit Rating Limited Dec 10, 2023 AA+ ST-1 Stable Dec 09, 2024 Alpha Credit Rating Limited         Half Year End (HY) Information  202512 HY Net Turnover(mn)  7465.17 HY Net Profit after tax(mn)  472.55 HY EPS  15.27  AGM Information   AGM Date  23 November, 2026 Record Date  26 October, 2026 Dividend(%)  77.00 (Cash- June 2026) Bonus Issue  10%-2018, 10%-2017, 15%-2016, 5%-2014, 10 13, 20%-2012, 25%-2011, 20%-2010, 20%-2009

   

Interim Financial Performance: 2026
Particulars	Unaudited / Audited
	Q1	Q2	Half Yearly	Q3	9 Months	Annual
	Ending on	Ending on	6 Months	Ending on		Ending on
	30-Sep-2025	31-Dec-2025	31-Dec-2025	31-Mar-2026		30-Jun-2026
Earnings Per Share (EPS)
Basic	7.080	8.200	15.270	4.670	19.940
Diluted*
Earnings Per Share (EPS) - continuing operations
Basic	7.080	8.200	15.270	4.670	19.940
Diluted*
Market price per share at period end

*As per BSEC Directive No. SEC/CMRRCD/2009-193/64, dated September 21, 2010.

*Note: For detail financial statements, please visit company’s website.

   

Financial Performance
Performance Year	Basic EPS Based On		Basic EPS (restated) Based On		Net Asset Value Per Share	Restated Net Asset Value Per Share	Net Profit After Tax(mn)		% Dividend	% Dividend Yield
	Continuous operations	Including Extra-Ordinary Income	Continuous operations	Including Extra-Ordinary Income			Continuous operations	Including Extra-Ordinary Income
2025	20.27	0	0	0	125.69	0	633.19	0	64%C	2.18
2024	21.46	0	0	0	111.94	0	670.52	0	63%C	2.57
2023	19.38	0	0	0	96.68	0	605.42	0	60%C	2.13
2022	19.39	0	0	0	83.36	0	605.67	0	60%C	2.02
2021	15.66	0	0	0	68.69	0	489.12	0	47%C	1.91

Financial Statements
Quarterly Financial Statement	http://www.ibnsinapharma.com/investors/financial-report/
Price Sensitive Information	https://www.ibnsinapharma.com/investors/price-sensitive-information

Close Price and Traded Volume Graph
Click here to view 1 month graph	Click here to view 3 month graph	Click here to view 6 month graph
Form	To